Sandra M. Herrmann

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

LaTonya J. Hickson, Larissa Prata, Shane A. Bobart et al. · EBioMedicine · 2019 · 1.3K citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study

Frank B. Cortazar, Zoé A. Kibbelaar, Ilya Glezerman et al. · Journal of the American Society of Nephrology · 2020 · 388 citations · Full text

Medicine, Immunology, Nephrology +14

Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation

G. Schmidmaier, Sandra M. Herrmann, J. Green et al. · Bone · 2006 · 260 citations

Medicine, Hematology, Bone Augmentation +9

Acute kidney injury in patients treated with immune checkpoint inhibitors

Shruti Gupta, Samuel Short, Meghan E. Sise et al. · Journal for ImmunoTherapy of Cancer · 2021 · 225 citations · Full text

Medicine, Nephrology, Oncology +16

Long‐term outcome of enzyme‐replacement therapy in advanced <scp>F</scp>abry disease: evidence for disease progression towards serious complications

Frank Weidemann, Markus Niemann, Stefan Störk et al. · Journal of Internal Medicine · 2013 · 218 citations · Full text

Medicine, Internal Medicine, Nephrology +10